CD70 anticorps (AA 129-193)
Aperçu rapide pour CD70 anticorps (AA 129-193) (ABIN1886003)
Antigène
Voir toutes CD70 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 129-193
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Synthetic peptide contain a sequence corresponding to a region within amino acids 129 and 193 of CD27L (CD70)
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- CD70 (CD70 Molecule (CD70))
-
Autre désignation
- CD27L(CD27L(CD70))
-
Sujet
-
The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family.This cytokine is a ligand for TNFRSF27/CD27.It is a surface antigen on activated, but not on resting, T and B lymphocytes.It induces proliferation of costimulated T cells, enhances the generation of cytolytic T cells, and contributes to T cell activation.This cytokine is also reported to play a role in regulating B-cell activation, cytotoxic function of natural killer cells, and immunoglobulin sythesis.[provided by RefSeq]
-
Poids moléculaire
- 21 kDa
-
ID gène
- 970
-
NCBI Accession
- NM_001252, NP_001243
-
Pathways
- Cancer Immune Checkpoints
Antigène
-